InnovITech took part in the Hungarian–Italian Medical Technology Business Day organized by the Embassy of Hungary in Rome. The event provided an excellent opportunity for innovative Hungarian companies interested in the Italian healthcare market to identify entry points, establish connections, and build partnerships.
Special thanks go to the Ministry of Foreign Affairs and Trade, as well as to the Embassy of Hungary in Rome and the Hungarian Trade Office, for their efforts in organizing the event and preparing high-level, professionally arranged meetings. The careful organization and coordination of targeted B2B sessions made it possible to conduct meaningful, content-focused discussions with key players in the Italian healthcare sector.
InnovITech was represented at the Rome event by Dr. Szabolcs Márien, Chief Executive Officer, Gábor Szarka, Business Director, and Dr. Gábor Guta, Scientific Director.
Following the morning market-focused and professional workshop, company presentation sessions took place, followed by more informal B2B discussions.
Organizations participating included Confimi Sanità (Confimi Industria), Tecnopolo SpA (supported by the Rome Chamber of Commerce), B-Sanità, Consorzio Italbiotec, and Forum Agenti — all of which have extensive partner networks and in-depth market knowledge.
InnovITech presented the following healthcare technology developments:
- Microbiolance – A bioinformatics and AI-based microbiome analysis service.
- GenFXPlorre – An AI-based analysis platform for uncovering relationships between functional genomic and clinical data profiles to support early diagnostics and therapy efficiency assessment (oncology).
- CTA – CML Treatment Assistant – A personalized therapy monitoring and therapy effectiveness evaluation solution (primarily for oncology but relevant to other disease areas as well).